InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: JimmyJams post# 72858

Thursday, 02/05/2015 4:45:03 PM

Thursday, February 05, 2015 4:45:03 PM

Post# of 80868
Musclepharm cannot expect much from investors being a highly dilutive public company. Musclepharm issues a ton of stocks each year to short term endorsements deals and to management and board members as stock grants that are vested over few years, while not being profitable at the same time. Not cool!

How could Musclepharm dilute the stock with 20% in 2014 when it didn't raise any capital but bought back stocks? it doesn't make any sense!